Targeting the microenvironment in acute myeloid leukemia
- PMID: 25921388
- PMCID: PMC4447552
- DOI: 10.1007/s11899-015-0255-4
Targeting the microenvironment in acute myeloid leukemia
Abstract
The bone marrow microenvironment plays a critical role in the development, progression, and relapse of acute myeloid leukemia (AML). Similar to normal hematopoietic stem cells, AML blasts express receptors on their surface, allowing them to interact with specific components of the marrow microenvironment. These interactions contribute to both chemotherapy resistance and disease relapse. Preclinical studies and early phase clinical trials have demonstrated the potential for targeting the tumor-microenvironment interactions in AML. Agents currently under investigation include hypoxia-inducible agents and inhibitors of CXCR4 and adhesion molecules such as VLA-4 and E-selectin.
Conflict of interest statement
Similar articles
-
Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.Br J Haematol. 2020 Jun;189(5):815-825. doi: 10.1111/bjh.16456. Epub 2020 Mar 5. Br J Haematol. 2020. PMID: 32135579 Review.
-
[CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].Bull Cancer. 2014 Jun;101(6):593-604. doi: 10.1684/bdc.2014.1925. Bull Cancer. 2014. PMID: 24977448 Review. French.
-
Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?Am J Hematol. 2016 May;91(5):507-17. doi: 10.1002/ajh.24312. Epub 2016 Apr 4. Am J Hematol. 2016. PMID: 26822317 Review.
-
Role of Microenvironment in Resistance to Therapy in AML.Curr Hematol Malig Rep. 2015 Jun;10(2):96-103. doi: 10.1007/s11899-015-0253-6. Curr Hematol Malig Rep. 2015. PMID: 25921386 Free PMC article. Review.
-
Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?Semin Cancer Biol. 2010 Jun;20(3):178-85. doi: 10.1016/j.semcancer.2010.07.001. Epub 2010 Jul 15. Semin Cancer Biol. 2010. PMID: 20637871 Review.
Cited by
-
A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia.Front Oncol. 2020 Aug 11;10:1579. doi: 10.3389/fonc.2020.01579. eCollection 2020. Front Oncol. 2020. PMID: 32850463 Free PMC article.
-
HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia.Cancer Biol Ther. 2016 Jun 2;17(6):625-34. doi: 10.1080/15384047.2016.1177679. Epub 2016 Apr 15. Cancer Biol Ther. 2016. PMID: 27082496 Free PMC article.
-
Resistance to targeted therapies: delving into FLT3 and IDH.Blood Cancer J. 2022 Jun 9;12(6):91. doi: 10.1038/s41408-022-00687-5. Blood Cancer J. 2022. PMID: 35680852 Free PMC article. Review.
-
Identification of prognostic genes in the acute myeloid leukemia microenvironment.Aging (Albany NY). 2019 Nov 18;11(22):10557-10580. doi: 10.18632/aging.102477. Epub 2019 Nov 18. Aging (Albany NY). 2019. PMID: 31740623 Free PMC article.
-
Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.Blood. 2022 Feb 24;139(8):1135-1146. doi: 10.1182/blood.2021010721. Blood. 2022. PMID: 34543383 Free PMC article. Clinical Trial.
References
-
- Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978;4(1-2):7–25. - PubMed
-
- Bendall LJ, et al. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Hematol. 1994;22(13):1252–60. - PubMed
-
- Garrido SM, et al. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5) Exp Hematol. 2001;29(4):448–57. - PubMed
-
- Ishikawa F, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007;25(11):1315–21. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical